Crossmark

Re: letter to the editor for the article “Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy”

Crossref DOI link: https://doi.org/10.1007/s00345-024-05255-z

Published Online: 2024-09-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rodler, Severin

Stief, Christian

Westhofen, Thilo
Funding

Funding for this research was provided by:

Klinikum der Universität München
License Information

Text and Data Mining valid from 2024-09-27

Version of Record valid from 2024-09-27
More Information

Article History

Received: 30 June 2024

Accepted: 1 September 2024

First Online: 27 September 2024

Declarations

:

: S. R. receives consultancy fees from Merck, MSD and Novartis and owns shares of Rocketlane Medical Ventures GmbH. The other authors report no conflict of interest.

Document is current

Any future updates will be listed below